MicroRNA-195 inhibits non-small cell lung cancer cell proliferation, migration and invasion by targeting MYB

Cancer Letters

Volumn 347, Issue 1, 2014, Pages 65-74

  Yongchun, Zhou ^a   Linwei, Tian ^b   Xicai, Wang ^a   Lianhua, Ye ^a   Guangqiang, Zhao ^a   Ming, Yu ^a   Guanjian, Li ^a   Yujie, Lei ^a   Yunchao, Huang ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Invasion; MiR 195; MYB; Non small cell lung cancer; Proliferation

Indexed keywords

MICRORNA; MICRORNA 195; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CONTROLLED STUDY; DISEASE ACTIVITY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MIGRATION INHIBITION; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN TARGETING; SEQUENCE ANALYSIS;

INVASION; MIR-195; MYB; NON-SMALL CELL LUNG CANCER; PROLIFERATION;

3' UNTRANSLATED REGIONS; CARCINOMA, NON-SMALL-CELL LUNG; CELL PROLIFERATION; DOWN-REGULATION; HUMANS; HYDROGEN-ION CONCENTRATION; LUNG NEOPLASMS; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; ONCOGENE PROTEINS V-MYB; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84897105541     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.01.019     Document Type: Article

References (41)

1. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J. Clin. 2010, 60:277-300.
2. Verdecchia A., Francisci S., Brenner H., Gatta G., Micheli A., Mangone L., Kunkler I., Group E.-W. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol. 2007, 8:784-796.
3. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
4. Farazi T.A., Spitzer J.I., Morozov P., Tuschl T. miRNAs in human cancer. J. Pathol. 2011, 223:102-115.
5. Cui F., Li X., Zhu X., Huang L., Huang Y., Mao C., Yan Q., Zhu J., Zhao W., Shi H. MiR-125b inhibits tumor growth and promotes apoptosis of cervical cancer cells by targeting phosphoinositide 3-kinase catalytic subunit delta. Cell. Physiol. Biochem.: Int. J. Exp. Cell. Physiol. Biochem. Pharmacol. 2012, 30:1310-1318.
6. Li H., Yang B.B. Stress response of glioblastoma cells mediated by miR-17-5p targeting PTEN and the passenger strand miR-17-3p targeting MDM2. Oncotarget 2012, 3:1653-1668.
7. Tang F., Zhang R., He Y., Zou M., Guo L., Xi T. MicroRNA-125b induces metastasis by targeting STARD13 in MCF-7 and MDA-MB-231 breast cancer cells. PLoS ONE 2012, 7:e35435.
8. Li Q., Zou C., Zou C., Han Z., Xiao H., Wei H., Wang W., Zhang L., Zhang X., Tang Q., Zhang C., Tao J., Wang X., Gao X. MicroRNA-25 functions as a potential tumor suppressor in colon cancer by targeting Smad7. Cancer Lett. 2013, 335:168-174.
9. Tsai W.C., Hsu P.W., Lai T.C., Chau G.Y., Lin C.W., Chen C.M., Lin C.D., Liao Y.L., Wang J.L., Chau Y.P., Hsu M.T., Hsiao M., Huang H.D., Tsou A.P. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology 2009, 49:1571-1582.
10. Ceppi P., Mudduluru G., Kumarswamy R., Rapa I., Scagliotti G.V., Papotti M., Allgayer H. Loss of miR-200c expression induces an aggressive, invasive, and chemoresistant phenotype in non-small cell lung cancer. Mol. Cancer Res.: MCR 2010, 8:1207-1216.
11. Flavin R.J., Smyth P.C., Laios A., O'Toole S.A., Barrett C., Finn S.P., Russell S., Ring M., Denning K.M., Li J., Aherne S.T., Sammarae D.A., Aziz N.A., Alhadi A., Sheppard B.L., Lao K., Sheils O.M., O'Leary J.J. Potentially important microRNA cluster on chromosome 17p13.1 in primary peritoneal carcinoma. Modern Pathol.: Off. J. US Can. Acad. Pathol. Inc. 2009, 22:197-205.
12. Soon P.S., Tacon L.J., Gill A.J., Bambach C.P., Sywak M.S., Campbell P.R., Yeh M.W., Wong S.G., Clifton-Bligh R.J., Robinson B.G., Sidhu S.B. MiR-195 and miR-483-5p identified as predictors of poor prognosis in adrenocortical cancer. Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 2009, 15:7684-7692.
13. Xu T., Zhu Y., Xiong Y., Ge Y.Y., Yun J.P., Zhuang S.M. MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells. Hepatology 2009, 50:113-121.
14. Wang X., Wang J., Ma H., Zhang J., Zhou X. Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer. Med. Oncol. 2012, 29:919-927.
15. Wang Y., Weng T., Gou D., Chen Z., Chintagari N.R., Liu L. Identification of rat lung-specific microRNAs by micoRNA microarray: valuable discoveries for the facilitation of lung research. BMC Genom. 2007, 8:29.
16. Wan H.Y., Guo L.M., Liu T., Liu M., Li X., Tang H. Regulation of the transcription factor NF-kappaB1 by microRNA-9 in human gastric adenocarcinoma. Mol. Cancer 2010, 9:16.
17. Hsu S.D., Chu C.H., Tsou A.P., Chen S.J., Chen H.C., Hsu P.W., Wong Y.H., Chen Y.H., Chen G.H., Huang H.D. miRNAMap 2.0: genomic maps of microRNAs in metazoan genomes. Nucl. Acids Res. 2008, 36:D165-D169.
18. Zanette D.L., Rivadavia F., Molfetta G.A., Barbuzano F.G., Proto-Siqueira R., Silva W.A., Falcao R.P., Zago M.A. miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia. Braz. J. Med. Biol. Res. 2007, 40:1435-1440.
19. Hannafon B.N., Sebastiani P., de las Morenas A., Lu J., Rosenberg C.L. Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancer. Breast Cancer Res.: BCR 2011, 13:R24.
20. Landi M.T., Zhao Y., Rotunno M., Koshiol J., Liu H., Bergen A.W., Rubagotti M., Goldstein A.M., Linnoila I., Marincola F.M., Tucker M.A., Bertazzi P.A., Pesatori A.C., Caporaso N.E., McShane L.M., Wang E. MicroRNA expression differentiates histology and predicts survival of lung cancer. Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 2010, 16:430-441.
21. Keller A., Leidinger P., Borries A., Wendschlag A., Wucherpfennig F., Scheffler M., Huwer H., Lenhof H.P., Meese E. miRNAs in lung cancer - studying complex fingerprints in patient's blood cells by microarray experiments. BMC Cancer 2009, 9:353.
22. Barshack I., Lithwick-Yanai G., Afek A., Rosenblatt K., Tabibian-Keissar H., Zepeniuk M., Cohen L., Dan H., Zion O., Strenov Y., Polak-Charcon S., Perelman M. MicroRNA expression differentiates between primary lung tumors and metastases to the lung. Pathol. Res. Pract. 2010, 206:578-584.
23. Qi J., Yu J.Y., Shcherbata H.R., Mathieu J., Wang A.J., Seal S., Zhou W., Stadler B.M., Bourgin D., Wang L., Nelson A., Ware C., Raymond C., Lim L.P., Magnus J., Ivanovska I., Diaz R., Ball A., Cleary M.A., Ruohola-Baker H. microRNAs regulate human embryonic stem cell division. Cell Cycle 2009, 8:3729-3741.
24. Sekiya Y., Ogawa T., Iizuka M., Yoshizato K., Ikeda K., Kawada N. Down-regulation of cyclin E1 expression by microRNA-195 accounts for interferon-beta-induced inhibition of hepatic stellate cell proliferation. J. Cell. Physiol. 2011, 226:2535-2542.
25. Roussel M., Saule S., Lagrou C., Rommens C., Beug H., Graf T., Stehelin D. Three new types of viral oncogene of cellular origin specific for haematopoietic cell transformation. Nature 1979, 281:452-455.
26. Fang F., Rycyzyn M.A., Clevenger C.V. Role of c-Myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cells. Endocrinology 2009, 150:1597-1606.
27. Ramsay R.G. C-Myb a stem-progenitor cell regulator in multiple tissue compartments. Growth Factors 2005, 23:253-261.
28. Ramsay R.G., Gonda T.J. MYB function in normal and cancer cells. Nat. Rev. Cancer 2008, 8:523-534.
29. Biroccio A., Benassi B., D'Agnano I., D'Angelo C., Buglioni S., Mottolese M., Ricciotti A., Citro G., Cosimelli M., Ramsay R.G., Calabretta B., Zupi G. C-Myb and Bcl-x overexpression predicts poor prognosis in colorectal cancer: clinical and experimental findings. Am. J. Pathol. 2001, 158:1289-1299.
30. Greco C., Alvino S., Buglioni S., Assisi D., Lapenta R., Grassi A., Stigliano V., Mottolese M., Casale V. Activation of c-MYC and c-MYB proto-oncogenes is associated with decreased apoptosis in tumor colon progression. Anticancer Res. 2001, 21:3185-3192.
31. Ramsay R.G., Friend A., Vizantios Y., Freeman R., Sicurella C., Hammett F., Armes J., Venter D. Cyclooxygenase-2, a colorectal cancer nonsteroidal anti-inflammatory drug target, is regulated by c-MYB. Cancer Res. 2000, 60:1805-1809.
32. Zhang J., Luo N., Luo Y., Peng Z., Zhang T., Li S. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb. Int. J. Oncol. 2012, 40:747-756.
33. Hobert O. miRNAs play a tune. Cell 2007, 131:22-24.
34. Peter M.E. Targeting of mRNAs by multiple miRNAs: the next step. Oncogene 2010, 29:2161-2164.
35. Liu L., Chen L., Xu Y., Li R., Du X. microRNA-195 promotes apoptosis and suppresses tumorigenicity of human colorectal cancer cells. Biochem. Biophys. Res. Commun. 2010, 400:236-240.
36. Lin Y., Wu J., Chen H., Mao Y., Liu Y., Mao Q., Yang K., Zheng X., Xie L. Cyclin-dependent kinase 4 is a novel target in micoRNA-195-mediated cell cycle arrest in bladder cancer cells. FEBS Lett. 2012, 586:442-447.
37. He J.F., Luo Y.M., Wan X.H., Jiang D. Biogenesis of MiRNA-195 and its role in biogenesis, the cell cycle, and apoptosis. J. Biochem. Mol. Toxicol. 2011, 25:404-408.
38. Yang X., Yin J., Yu J., Xiang Q., Liu Y., Tang S., Liao D., Zhu B., Zu X., Tang H., Lei X. miRNA-195 sensitizes human hepatocellular carcinoma cells to 5-FU by targeting BCL-w. Oncol. Rep. 2012, 27:250-257.
39. Purow B. The elephant in the room: do microRNA-based therapies have a realistic chance of succeeding for brain tumors such as glioblastoma?. J. Neurooncol. 2011, 103:429-436.
40. Drabsch Y., Robert R.G., Gonda T.J. MYB suppresses differentiation and apoptosis of human breast cancer cells. Breast Cancer Res.: BCR 2010, 12:R55.
41. Knopfova L., Benes P., Pekarcikova L., Hermanova M., Masarik M., Pernicova Z., Soucek K., Smarda J. c-Myb regulates matrix metalloproteinases 1/9, and cathepsin D: implications for matrix-dependent breast cancer cell invasion and metastasis. Mol. Cancer 2012, 11:15.